Get your #Olympics on! Studies in JAMA focus on the health of athletes. Specifically on heat-related illness as well as ACL injuries in female athletes. https://zurl.co/vJS1
Buck Institute for Research on Aging
Research
Novato, CA 16,077 followers
Live better longer.
About us
Novato’s Buck Institute is the largest independent scientific institute in the Bay Area. The Buck aims to end the threat of age-related diseases for this and future generations by bringing together the most capable and passionate scientists from a broad range of disciplines to identify and impede the ways in which we age. Its goal is to increase human healthspan, or the healthy years of life. Globally recognized as the pioneer and leader in efforts to target aging, the number one risk factor for serious diseases including Alzheimer’s, Parkinson’s, cancer, macular degeneration, heart disease, and diabetes, the Buck wants to help people live better longer. For more information and to visit the Buck: https://www.buckinstitute.org/
- Website
-
http://buckinstitute.org/
External link for Buck Institute for Research on Aging
- Industry
- Research
- Company size
- 51-200 employees
- Headquarters
- Novato, CA
- Type
- Nonprofit
- Founded
- 1999
- Specialties
- Aging, Chronic Disease, Geroscience, and Healthspan
Locations
-
Primary
8001 Redwood Boulevard
Novato, CA 94945, US
Employees at Buck Institute for Research on Aging
Updates
-
Big breakthroughs usually start with the tiniest findings. Recent study from the Eric Verdin and Birgit Schilling labs is a case in point. Successful efforts to bring sirtuin 5 “back from the dead” could further efforts to target longevity. Read all about it in our latest blog post. https://lnkd.in/g4wKSKRe
-
Listen to our latest blog post! Dr. Nathan Price is CSO of Thorne, author of The Age of Scientific Wellness, and Co-Director of The Center for Human Healthspan at Buck. Dr. Price discusses what do we really want from our healthcare system, and how can AI help us get it sooner. https://lnkd.in/gw8Qn-xa
-
Two new proteins have been linked to #Parkinsons. Study in Nature Structural & Molecular Biology shows NAP1 and SINTBAD are involved in the regulation of #mitophagy. The work opens new avenues to promote mitochondrial and neuronal health. https://lnkd.in/gcCpUYAX
Control of mitophagy initiation and progression by the TBK1 adaptors NAP1 and SINTBAD - Nature Structural & Molecular Biology
nature.com
-
Tickets are are almost sold out! Register today: https://lnkd.in/gNWeH-TN Anyone hoping to live long enough to become an older adult needs to be their own advocate when they walk into the exam room. Dr. Newman is a practicing geriatrician who can help us ask the right questions.
-
Join us on Monday, Aug 12 at the Buck (or on Zoom) for the Inaugural Judith Campisi Symposium! Cellular Senescence: The Road to Immortality Register today: https://lnkd.in/gG_ZH7RZ This event is dedicated to the remarkable legacy of internationally renowned scientist Judith Campisi, who passed away at the age of 75 on January 19, 2024. Judith Campisi, known affectionately as Judy, held key positions at the Buck Institute for Research on Aging and Lawrence Berkeley National Laboratory. Her groundbreaking research in senescence and aging reshaped our comprehension of these phenomena. Particularly noteworthy was her shift from cancer to senescence research, which led to pivotal discoveries such as identifying the SA-β-Gal marker for senescent cells. The symposium will continue her legacy and is directed at understanding cell senescence and fate in aging and disease. Speakers include Jan Vijg, Simona Parrinello, Christopher Wiley, Cristina Montagna, Scott Lowe, Norman Sharpless, Thomas Rando, John Sedivy, Junko Oshima, Jennifer Elisseeff, Patty Lee, Fabrizio d'Adda di Fagagna, Lisa Ellerby, Paul Robbins, Yousin Suh, Birgit Schilling, Pura Munoz-Canoves, Miranda Orr
Cellular Senescence: The Road to Immortality - BUCK
buckinstitute.org
-
Lots of info from a drop of #blood! Study in Nature Medicine shows blood proteins predict risk of developing more than 60 diseases, based on largest proteomics study to date from over 40,000 UK Biobank participants. Results outperform current models https://lnkd.in/dmmXguMS
Proteomic signatures improve risk prediction for common and rare diseases - Nature Medicine
nature.com
-
Switching off an inflammatory protein increased healthy #lifespan of mice by almost 25%. Study in Nature showed treatment with IL-11 antibody reduced #aging in several tissues. #Antibody is now in clinical trials for other conditions. Next step humans? https://lnkd.in/guvdqyFH
Inhibition of IL-11 signalling extends mammalian healthspan and lifespan - Nature
nature.com
-
Our very own Julie K Andersen delivers keynote at 16th Int'l Symposium on Neurobiology and Neuroendocrinology of Aging in Bregenz, Austria! “Development of mitophagy-inducing small molecules as therapeutics for aging and #Alzheimers disease” https://lnkd.in/gxYyA7GP @JKAndersenBuck
Neurobiology and Neuroendocrinology of Aging
neurobiology-and-neuroendocrinology-of-aging.org
-
Study in Advanced Science News deepens our understanding of #neurodegenerative diseases linked to protein aggregation. Researchers find formation of proteins into lipid droplets may help dissolve aggregated protein. Discovery could lead to new therapies. https://lnkd.in/gJZHHtdn
Phase Separation and Aggregation of α‐Synuclein Diverge at Different Salt Conditions
onlinelibrary.wiley.com